Lipid prodrugs for oral administration

Details Lipid prodrugs for oral administration Lipid prodrugs for oral administration

C - Chemistry, Metallurgy

07

K

C07K 2/00 (2006.01) A61K 31/66 (2006.01) A61K 31/70 (2006.01) A61K 38/00 (2006.01) A61K 47/48 (2006.01) C07F 9/40 (2006.01) C07F 9/547 (2006.01) C07F 9/655 (2006.01) C07H 15/04 (2006.01) C07H 15/20 (2006.01) C07H 19/10 (2006.01) C07H 19/16 (2006.01) C07K 7/00 (2006.01) C07K 14/00 (2006.01)

Patent

CA 2149754

2149754 9413324 PCTABS00032 The oral delivery of many classes of drugs is facilitated by converting drugs having suitable functional groups to 1-0-alkyl-, 1-0-acyl-, 1-S-acyl, and 1-S-alkyl-sn-glycero-3-phosphate derivatives. The method confers the ability to be absorbed through the digestive tract to drugs that are not orally bioavailable in the non-derivatized state, and enhances the effectiveness of drugs that are poorly absorbed or rapidly eliminated. The method provides orally bioavailable lipid prodrugs of pharmaceutical compounds having diverse physiological activities, including anticancer and antiviral agents, anti-inflammatory agents, antihypertensives and antibiotics. Potency of the lipid prodrugs is comparable to that of the corresponding non-derivatized drugs.

Affiliated with

Also associated with

Rating

Lipid prodrugs for oral administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipid prodrugs for oral administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipid prodrugs for oral administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1463819